Research Paper Volume 12, Issue 6 pp 5259—5279

Figure 7. Correlation analysis for potential hsa-miR-145-5p-target gene pairs in colorectal cancer. (A) The visual hsa-miR-145-5p-target gene network. (B) The expression correlation of hsa-miR-145-5p with CBFB in colorectal cancer. (C) The expression correlation of hsa-miR-145-5p with CD44 in colorectal cancer. (D) The expression correlation of hsa-miR-145-5p with CDK4 in colorectal cancer. (E) The expression correlation of hsa-miR-145-5p with CDK6 in colorectal cancer. (F) The expression correlation of hsa-miR-145-5p with MMP1 in colorectal cancer. (G) The expression correlation of hsa-miR-145-5p with MMP12 in colorectal cancer. (H) The expression correlation of hsa-miR-145-5p with MYC in colorectal cancer. (I) The expression correlation of hsa-miR-145-5p with PIGF in colorectal cancer. (J) The expression correlation of hsa-miR-145-5p with ROBO2 in colorectal cancer. (K) The expression correlation of hsa-miR-145-5p with SNTB1 in colorectal cancer. (L) The expression correlation of hsa-miR-145-5p with TGFBI in colorectal cancer. (M) The expression correlation of hsa-miR-145-5p with VEGFA in colorectal cancer. (N) The expression correlation of hsa-miR-145-5p with PSAT1 in colorectal cancer. (O) The expression correlation of hsa-miR-145-5p with LMNB2 in colorectal cancer. (P) The expression correlation of hsa-miR-145-5p with RAB3IP in colorectal cancer. (Q) The expression correlation of hsa-miR-145-5p with C11orf65 in colorectal cancer. (R) The expression correlation of hsa-miR-145-5p with CRNDE in colorectal cancer. P-value < 0.05 was considered as statistically significant.